BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38470543)

  • 1. Deubiquitinase BRCC3 promotes the migration, invasion and EMT progression of colon adenocarcinoma by stabilizing MET expression.
    Feng X; He S; Chen Y; Zhang L
    Genes Genomics; 2024 May; 46(5):637-646. PubMed ID: 38470543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deubiquitinase BRCC3 increases the stability of ZEB1 and promotes the proliferation and metastasis of triple-negative breast cancer cells.
    Huang Q; Zheng S; Gu H; Yang Z; Lu Y; Yu X; Guo G
    Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):564-575. PubMed ID: 38449391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro.
    Zhang F; Zhou Q
    Mol Med Rep; 2018 Dec; 18(6):4886-4894. PubMed ID: 30272359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-708 targeting ZNF549 regulates colon adenocarcinoma development through PI3K/AKt pathway.
    Zhao Z; Qin X
    Sci Rep; 2020 Oct; 10(1):16729. PubMed ID: 33028966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Invasion and Metastasis of Colon Adenocarcinoma (COAD) Induced by SALL4.
    Zhang W; Hu Y; Zhang W; Yi K; Xu X; Chen Z
    J Immunol Res; 2022; 2022():9385820. PubMed ID: 35692499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00342 regulates cell proliferation, apoptosis, migration and invasion in colon adenocarcinoma via miR-545-5p/MDM2 axis.
    Miao Z; Liu S; Xiao X; Li D
    Gene; 2020 Jun; 743():144604. PubMed ID: 32213297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNNT1, a prognostic indicator in colon adenocarcinoma, regulates cell behaviors and mediates EMT process.
    Hao YH; Yu SY; Tu RS; Cai YQ
    Biosci Biotechnol Biochem; 2020 Jan; 84(1):111-117. PubMed ID: 31512553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of extracellular matrix-related biomarkers in colon adenocarcinoma by bioinformatics and experimental validation.
    Yin Y; Yang X; Cheng Z; Wang H; Lei J; Wang D; Wang P; Li B; Mi J; Yuan Q
    Front Immunol; 2024; 15():1371584. PubMed ID: 38694509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AEBP1, a prognostic indicator, promotes colon adenocarcinoma cell growth and metastasis through the NF-κB pathway.
    Xing Y; Zhang Z; Chi F; Zhou Y; Ren S; Zhao Z; Zhu Y; Piao D
    Mol Carcinog; 2019 Oct; 58(10):1795-1808. PubMed ID: 31219650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA ILF3-AS1 Promotes the Progression of Colon Adenocarcinoma Cells Through the miR-619-5p/CAMK1D Axis.
    Liu W; Li S
    Onco Targets Ther; 2021; 14():1861-1872. PubMed ID: 33737811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AEBP1 Is One of the Epithelial-Mesenchymal Transition Regulatory Genes in Colon Adenocarcinoma.
    Li D; Liu Z; Ding X; Qin Z
    Biomed Res Int; 2021; 2021():3108933. PubMed ID: 34938806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETV4 transcriptionally activates HES1 and promotes Stat3 phosphorylation to promote malignant behaviors of colon adenocarcinoma.
    Yao D; Bao Z; Qian X; Yang Y; Mao Z
    Cell Biol Int; 2021 Oct; 45(10):2129-2139. PubMed ID: 34270850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression.
    Baldi S; Zhang Q; Zhang Z; Safi M; Khamgan H; Wu H; Zhang M; Qian Y; Gao Y; Shopit A; Al-Danakh A; Alradhi M; Al-Nusaif M; Zuo Y
    J Cell Mol Med; 2022 Dec; 26(24):5984-5997. PubMed ID: 36420658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcriptome signature analysis of the epithelial-mesenchymal transition and immune cell infiltration in colon adenocarcinoma.
    Heryanto YD; Imoto S
    Sci Rep; 2023 Oct; 13(1):18383. PubMed ID: 37884639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCDC12 promotes tumor development and invasion through the Snail pathway in colon adenocarcinoma.
    Du F; Peng L; Wang Q; Dong K; Pei W; Zhuo H; Xu T; Jing C; Li L; Zhang J
    Cell Death Dis; 2022 Feb; 13(2):187. PubMed ID: 35217636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR‑205 suppresses cell migration, invasion and EMT of colon cancer by targeting mouse double minute 4.
    Fan Y; Wang K
    Mol Med Rep; 2020 Aug; 22(2):633-642. PubMed ID: 32467998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIG1 domain family member 1A disrupts proliferation, migration, and invasion of colon adenocarcinoma cells.
    Xu Z; Sun J; Mao Y; Chen Y; Zhang T; Qin Y; Hua D
    Bioengineered; 2021 Dec; 12(2):10501-10511. PubMed ID: 34787061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis.
    Yu S; Zhao H; Meng H; Shi S; Cao S; Bian T; Ruan C
    Genet Res (Camb); 2023; 2023():8586507. PubMed ID: 37113556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
    Yang Y; Wang G; Zhu D; Huang Y; Luo Y; Su P; Chen X; Wang Q
    Int J Oncol; 2017 Aug; 51(2):515-524. PubMed ID: 28627611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of neuropilin-1 silencing on the transforming growth factor-β1-mediated epithelial-mesenchymal transition of colon cancer SW480 cells and its effect on the proliferation and migration of colon cancer cells.
    Zhu B; Zhan QQ; Liu QY; Yang X; Ge YH; Ding GY; Guo S; Xu WG
    J Physiol Pharmacol; 2022 Apr; 73(2):. PubMed ID: 36193963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.